NEW YORK (360Dx) – Rapid point-of-care diagnostics firm POC Medical Systems today announced it raised $21 million in a Series A funding round.

The funds will go toward clinical beta testing and initial commercialization of a rapid, portable breast cancer screening test, MammoAlert, which is based on the firm's Pandora CDx microfluidics-based platform.

The blood-based test will enable breast cancer screening in regions where screening methods are not accessible to many woman, such as India where POC will initially launch MammoAlert.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.